J&J business development exec sees China as major source of biotech innovation

Johnson & Johnson Medical Products company in Markham, Ontario

JHVEPhoto/iStock Editorial via Getty Images

Although the U.S. is still the leading country behind biotech innovation, China is close behind, according to a Johnson & Johnson (NYSE:JNJ) business development executive.

Nauman Shah, global head of business development for Johnson & Johnson Business Development, said that he was very impressed

Leave a Reply

Your email address will not be published. Required fields are marked *